Table 5.
Country | β-Blockers | Anticonvulsants | Fluoroquinolones | Parabens | References |
---|---|---|---|---|---|
South Africa | 0.96–39,000 | 4.0–94 | 110–2257 | 0–1988 | [31,36,44,45,54] |
Latvia | 0–150 | 18–50 | 250–400 | - | [55] |
Egypt | 0–187 | 0–342 | - | 0–6380 | [56,57,58] |
Kenya | - | 0–430 | - | 30–1160 | [59,60] |
Spain | 10–6066 | 28–283 | 0–2153 | 14–720 | [21,61,62,63] |
Italy | 0–57 | 0–137 | - | - | [64] |
Pakistan | 0.99–452 | 11–15 | 2–37,000 | 110–228 | [65,66] |
China | 0–995 | 23–115 | 0–2032 | 0–5960 | [65,66,67,68,69,70,71] |
Brazil | 0.02–1.89 | 69 | 90–788 | [72,73,74,75] | |
Canada | 114 | 20 | 34 | - | [76,77,78] |
Poland | 69–205 | 2.0 | 248.7 | 0.01–5.03 | [79,80,81,82] |
Portugal | 220–690 | 0.32–1.60 | 2.1–51 | [83,84] | |
Turkey | 0.92–24.25 | 17,000–33,000 | [85] | ||
United Kingdom | 93–388 | 13–56 | 180 | 2642–11,601 | [86,87] |
South Africa | 0–28 | - | 0–43 | 0–937 | This study |